ACTU CIK: 1652935

Actuate Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
−21.6
FY24:
−21.8
FY25:
−19.2
Change from FY22 to FY25
millions USD
FY22:
19.3
FY23:
4.13
FY24:
27.5
FY25:
23.7

All amounts in millions USD FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data